NDC product
Aspirin
NDC 36800-968 · TOP CARE (Topco Associates LLC)
Key facts
| Product NDC | 36800-968 |
|---|---|
| Proprietary name | Aspirin |
| Nonproprietary name | Aspirin |
| Substances | ASPIRIN |
| Dosage form | TABLET, COATED |
| Route | ORAL |
| Labeler | TOP CARE (Topco Associates LLC) |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M013 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] and 1 more |
| Marketing start | Apr 1, 2020 |
| Marketing end | Apr 28, 2028 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory